T J Colgan

Summary

Affiliation: Mount Sinai Hospital
Country: Canada

Publications

  1. ncbi The practice of pathology in Canada: decreasing pathologist supply and uncertain outcomes
    Terence J Colgan
    Sections of Gynecological and Cytopathology Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
    Arch Pathol Lab Med 136:90-4. 2012
  2. ncbi Disclosure of diagnostic errors: the death knell of retrospective pathology reviews?
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    J Low Genit Tract Dis 9:216-8. 2005
  3. ncbi Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Int J Gynecol Pathol 22:109-20. 2003
  4. ncbi Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas
    Terence J Colgan
    Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Am J Surg Pathol 27:167-77. 2003
  5. ncbi Screening for cervical disease in mature women: strategies for improvement
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario
    Cancer 96:195-203. 2002
  6. ncbi Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy
    Terence J Colgan
    Department of Laboratory Medicine and Pathology, Mount Sinai Hospital, Toronto, Canada
    Gynecol Oncol 85:397-403. 2002
  7. ncbi Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status
    T J Colgan
    Mount Sinai Hospital and the Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
    Am J Surg Pathol 25:1283-9. 2001
  8. ncbi Appropriate procedures for the safe handling and pathologic examination of technetium-99m-labelled specimens
    T J Colgan
    Toronto Medical Laboratories, University Health Network UHN
    CMAJ 164:1868-71. 2001
  9. ncbi The 2006 consensus guidelines for the management of women with abnormal cervical screening tests: challenges remain
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Cancer Cytopathol 118:233-7. 2010
  10. ncbi Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Cancer 102:362-7. 2004

Collaborators

Detail Information

Publications32

  1. ncbi The practice of pathology in Canada: decreasing pathologist supply and uncertain outcomes
    Terence J Colgan
    Sections of Gynecological and Cytopathology Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada
    Arch Pathol Lab Med 136:90-4. 2012
    ..Trends in the supply of pathologists in Canada's managed care system may provide some useful insights in any analysis and projection of future pathologist needs in the United States...
  2. ncbi Disclosure of diagnostic errors: the death knell of retrospective pathology reviews?
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    J Low Genit Tract Dis 9:216-8. 2005
    ..Retrospective pathology review would become so burdensome that its survival would be in jeopardy-unless measures are undertaken to ameliorate the anticipated adverse consequences...
  3. ncbi Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Int J Gynecol Pathol 22:109-20. 2003
    ..The adoption of these methods should increase our knowledge of early-stage tubal carcinoma and may add to our understanding of the development of ovarian-epithelial neoplasia...
  4. ncbi Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas
    Terence J Colgan
    Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Am J Surg Pathol 27:167-77. 2003
    ..In some cases with complications, uterine and/or cervical necrosis occurred. The applicability of these findings for UAE patients who have been successfully treated and not resected is uncertain...
  5. ncbi Screening for cervical disease in mature women: strategies for improvement
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario
    Cancer 96:195-203. 2002
    ..Strategies for improving screening in this age group were identified through examination of recent Pap test history of women with high grade squamous intra-epithelial lesions (HSIL)...
  6. ncbi Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy
    Terence J Colgan
    Department of Laboratory Medicine and Pathology, Mount Sinai Hospital, Toronto, Canada
    Gynecol Oncol 85:397-403. 2002
    ..This study sought to assess the utility of peritoneal lavage cytology at the time of PO in detecting occult malignancy in this group of patients...
  7. ncbi Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status
    T J Colgan
    Mount Sinai Hospital and the Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
    Am J Surg Pathol 25:1283-9. 2001
    ..The entire ovaries and tubes from PO patients should be submitted for histologic examination to identify malignancy...
  8. ncbi Appropriate procedures for the safe handling and pathologic examination of technetium-99m-labelled specimens
    T J Colgan
    Toronto Medical Laboratories, University Health Network UHN
    CMAJ 164:1868-71. 2001
    ..This quarantine does delay the reporting of pathology results to surgeons, oncologists and other clinicians, but it does not adversely affect final patient management...
  9. ncbi The 2006 consensus guidelines for the management of women with abnormal cervical screening tests: challenges remain
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Cancer Cytopathol 118:233-7. 2010
    ..In light of these challenges, the cytopathology community has an opportunity to play an active role in integrating data, defining risk, and recommending proper management for women screened for cervical cancer...
  10. ncbi Results of the implementation of liquid-based cytology-SurePath in the Ontario screening program
    Terence J Colgan
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    Cancer 102:362-7. 2004
    ..The objective of the current study was to evaluate the adequacy and detection rates of SurePath after its implementation in Ontario...
  11. ncbi Utility of p16(ink4a) immunocytochemistry in liquid-based cytology specimens from women treated for high-grade squamous intraepithelial lesions
    Vasiliki Bessie Carydis
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
    Acta Cytol 51:517-22. 2007
    ....
  12. ncbi Reparative changes and the false-positive/false-negative Papanicolaou test: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    T J Colgan
    Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario
    Arch Pathol Lab Med 125:134-40. 2001
    ..Underdiagnosing epithelial abnormalities as repair is also a source of false-negative Papanicolaou test results...
  13. ncbi Fertility-sparing surgery, with subsequent pregnancy, in persistent gestational trophoblastic neoplasia: case report
    A M Case
    Division of Reproductive Sciences, Division of Ultrasound and Department of Laboratory Medicine and Pathobiology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada
    Hum Reprod 16:360-4. 2001
    ..The literature is reviewed and potential pregnancy complications of this management, particularly uterine rupture, are discussed...
  14. ncbi Pap test results. Responding to Bethesda system reports
    T J Colgan
    Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario
    Can Fam Physician 47:1425-30. 2001
    ..CONCLUSION: Management of women following Pap tests is determined by both the adequacy of the test and diagnoses based on the results...
  15. ncbi Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroids
    Andrea Milic
    Department of Medical Imaging, University of Toronto, 657 University Avenue, Mulock Larkin Wing, Room 1-042, Toronto, Ontario M5G 2C4, Canada
    Cardiovasc Intervent Radiol 29:694-8. 2006
    ..Our preliminary results suggest that RFA is a technically feasible treatment for symptomatic uterine fibroids in appropriately selected patients...
  16. ncbi Choriocarcinoma arising in a serous carcinoma of ovary: an example of histopathology driving treatment
    Sara Hafezi-Bakhtiari
    Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON
    J Obstet Gynaecol Can 32:698-702. 2010
    ..Choriocarcinoma within an ovarian carcinoma is exceptionally rare. Nevertheless, recognition of this mixed tumour is important for administration of appropriate chemotherapy...
  17. ncbi Chordoma arising in a mature cystic teratoma of the ovary: a case report
    Facundo Las Heras
    Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ont, Canada
    Pathol Res Pract 203:467-71. 2007
    ..These results are concordant with previous studies, showing chromosomal anomalies in chromosomes X and 7 in MCTO and chordomas, respectively...
  18. ncbi Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection
    Diane Davis Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY, USA
    J Low Genit Tract Dis 12:71-81. 2008
    ..To provide updated management guidelines according to cervical cytology specimen adequacy and techniques to optimize adequacy based on literature review and expert opinion...
  19. ncbi Papanicolaou tests with mixed high-grade and low-grade squamous intraepithelial lesion features: distinct performance in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytopathology
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, FL, USA
    Arch Pathol Lab Med 130:456-9. 2006
    ..Participant performance on conventional mixed cases is distinctly different from performance on ThinPrep mixed cases...
  20. ncbi Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, FL, USA
    Arch Pathol Lab Med 130:332-6. 2006
    ..In ThinPrep specimens, however, these groups are more likely to be labeled as glandular lesions, owing to their smooth contoured borders and small nuclei...
  21. ncbi Precision in gynecologic cytologic interpretation: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital, Miami, Fla, USA
    Arch Pathol Lab Med 127:1413-20. 2003
    ..Cytologic interpretations of LSIL are made with greater precision than those of HSIL and may represent a more appropriate endpoint to measure the precision performance of gynecologic cytology laboratories...
  22. ncbi Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma
    Jurgen M J Piek
    Int J Gynecol Pathol 22:315-6; author reply 315-6. 2003
  23. ncbi Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
    Amy Finch
    The Centre for Research in Women's Health, 790 Bay Street, 7th Floor, Toronto, ON, Canada M5G 1N8
    Gynecol Oncol 100:58-64. 2006
    ..A significant proportion of these appear to originate in the fallopian tube. No cancers were detected among women who had the operation at age 39 or younger...
  24. ncbi Programmatic assessments of the clinical effectiveness of gynecologic liquid-based cytology
    Terence J Colgan
    Cancer 99:259-62. 2003
  25. ncbi Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington 40526 0298, USA
    Arch Pathol Lab Med 128:1224-9. 2004
    ..The 2001 Bethesda System for the reporting of cervical cytology specimens and the use of new liquid-based and human papillomavirus testing technologies have led to changes in cervical cytology reporting practices...
  26. ncbi Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts?
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, Fla, USA
    Arch Pathol Lab Med 129:609-13. 2005
    ..However, the reliability of expert opinion alone in selecting slides of a specific cytodiagnosis that can be reproducibly and reliably identified by subsequent reviewers has not been determined...
  27. ncbi Altered recognition of reparative changes in ThinPrep specimens in the College of American Pathologists Gynecologic Cytology Program
    Tamela M Snyder
    Department of Pathology, The Methodist Hospital, Houston, Tex, USA
    Arch Pathol Lab Med 129:861-5. 2005
    ....
  28. ncbi Measuring the significance of participant evaluation of acceptability of cases in the College of American Pathologists Interlaboratory Comparison Program in cervicovaginal cytology
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, FL, USA
    Arch Pathol Lab Med 129:1093-6. 2005
    ..These results support the use of participant evaluation of cases to continually improve the quality of cases in this program...
  29. ncbi Robustness of validation criteria in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, Fla, USA
    Arch Pathol Lab Med 130:1119-22. 2006
    ..These results have implications for the design of fair proficiency tests. Proficiency testing can be designed with the necessary number of reviews needed for slide validation...
  30. ncbi Interinstitutional pathology consultations. A reassessment
    Michele M Weir
    Department of Pathology, London Health Sciences Centre, University of Western Ontario, London, Canada
    Am J Clin Pathol 120:405-12. 2003
    ..Discordant IPCs may be due to factors other than interpretation difference...
  31. ncbi Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program
    Andrew A Renshaw
    College of American Pathologists Gynecologic Cytology Program, Northfield, Ill, USA
    Arch Pathol Lab Med 128:17-22. 2004
    ....
  32. ncbi Costs of prophylactic resection
    Terence J Colgan
    CMAJ 169:105. 2003